
塞瓦桑特安尼米爾(“Ceva”)和IDT Biologika有限公司(“IDT”)今天宣布,他們已經(jīng)成功地完成了收購IDT的由塞瓦獸醫(yī)生物制藥和R&d活動。
產(chǎn)品組合將盡快轉(zhuǎn)移到Ceva品牌。將在IDT現(xiàn)有的Dessau網(wǎng)站內(nèi)建立一個專注于豬疫苗的新全球創(chuàng)新中心。
法國最大的獸醫(yī)生物制藥公司Ceva鞏固了在法國大陸的投資,特別是在Laval,在那里建立了其伴侶動物領域的全球創(chuàng)新中心。

2500萬歐元的先進工業(yè)基礎設施
自收購Sogeval(2014年)以來,CevaSantéAnimale已將其Laval工廠作為其全球?qū)I(yè)中心,致力于伴侶動物業(yè)。
Ceva Laval校區(qū)擁有創(chuàng)新的組織模式,在一個校園內(nèi)匯集了開發(fā),生產(chǎn)和快速交付創(chuàng)新產(chǎn)品所需的所有人力和工業(yè)技能,與市場需求保持一致。研發(fā)團隊與質(zhì)量保證,生產(chǎn)和供應鏈部門相互聯(lián)系,并得到現(xiàn)場支持辦公室的支持。
Some pet investments perform better than others.

Animal owners continue to spend money for their companions whether it's for food, medicine or veterinary care. Since 1994, the pet industry has consistently risen with expenditures topping out at $72.56 billion last year, according to the American Pet Products Association. APPA estimates that the industry will climb to $75.38 billion this year. "There are more opportunities in the pet industry than many investors may realize," says Rich Messina, a senior vice president at E-Trade Financial, a New York-based brokerage company. Here are seven ways to invest in the pet industry, ranging from stocks to a handful of exchange-traded and mutual funds.